Federal Register / Vol. 73, No. 42 / Monday, March 3, 2008 / Notices 11423 

Executive Blvd., Room 8053, Bethesda, MD 

20892, 301/435–1822, githenss@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel, Antibody 

Array for Cancer Detection. 

Date: March 26–27, 2008. 

Time: 9 a.m. to 5 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: Bethesda Marriott Suites, 6711 

Democracy Boulevard, Bethesda, MD 20817. 

Contact Person: Sherwood Githens, PhD, 

Scientific Review Officer, Special Review 

and Logistics Branch, Division of Extramural 

Activities, National Cancer Institute, 6116 

Executive Blvd., Room 8053, Bethesda, MD 

20892, 301/435–1822, githenss@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel, Cancer 

Stem Cells. 

Date: March 27, 2008. 

Time: 1 p.m. to 5 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: National Institutes of Health, 6116 

Executive Boulevard, Rockville, MD 20892 

(Telephone Conference Call). 

Contact Person: Irina Gordienko, PhD, 

Scientific Review Officer, Special Review 

and Logistics Branch, Division of Extramural 

Activities, National Cancer Institute, NIH, 

6116 Executive Blvd., Room 7073, Bethesda, 

MD 20892, 301–594–1566, 

gordienkoiv@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel, Portable 

Energy Balance Review Panel (PEBRP). 

Date: April 2, 2008. 

Time: 8 a.m. to 3 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: Bethesda Marriott Suites, 6711 

Democracy Boulevard, Bethesda, MD 20817. 

Contact Person: C. Michael Kerwin, PhD, 

MPH, Scientific Review Officer, Special 

Review and Logistics Branch, Division of 

Extramural Activities, National Cancer 

Institute, NIH, 6116 Executive Blvd., Rm. 

8057, Bethesda, MD 20892–8329, 301–496–

7421, kerwinm@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel, A webbased tailored health behavior intervention 

for African American colon cancer. 

Date: April 2, 2008. 

Open: 3 p.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Bethesda Marriott Suites, 6711 

Democracy Boulevard, Bethesda, MD 20817. 

Contact Person: C. Michael Kerwin, PhD, 

MPH, Scientific Review Officer, Special 

Review and Logistics Branch, Division of 

Extramural Activities, National Cancer 

Institute, NIH, 6116 Executive Blvd., Rm. 

8057, Bethesda, MD 20892–8329, 301–496–

7421, kerwinm@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel, 

Development of Clinical Mass Spectrometric 

Immunoassays. 

Date: April 3, 2008. 

Time: 11 a.m. to 5 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: National Institutes of Health, 6116 

Executive Boulevard, CR 6008, Rockville, MD 

20852 (Telephone Conference Call). 

Contact Person: Sherwood Githens, PhD, 

Scientific Review Officer, Special Review 

and Logistics Branch, Division of Extramural 

Activities, National Cancer Institute, 6116 

Executive Blvd., Room 8053, Bethesda, MD 

20892, 301/435–1822, githenss@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel, Network 

for Translational Research: Optical Imaging 

(NTROI). 

Date: June 2–3, 2008. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hilton Washington DC North—

Gaithersburg, 620 Perry Parkway, 

Gaithersburg, MD 20877. 

Contact Person: Kenneth L. Bielat, PhD, 

Scientific Review Officer, Special Review 

Logistics Branch, Division of Extramural 

Activities, National Cancer Institute, 6116 

Executive Boulevard, Room 7147, Bethesda, 

MD 20892–8329, 301–496–7576, 

bielatk@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel, Cancer 

Prevention Research. 

Date: June 17–18, 2008. 

Time: 7 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Renaissance M Street Hotel, 1143 

New Hampshire Avenue, NW., Washington, 

DC 20037. 

Contact Person: Irina Gordienko, PhD, 

Scientific Review Officer, Scientific Review 

and Logistics Branch, Division of Extramural 

Activities, National Cancer Institute, NIH, 

6166 Executive Blvd., Rm. 7073, Bethesda, 

MD 20892, 301–594–1566, 

gordienkoiv@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.392, Cancer Construction; 

93.393, Cancer Cause and Prevention 

Research; 93.394, Cancer Detection and 

Diagnosis Research; 93.395, Cancer 

Treatment Research; 93.396, Cancer Biology 

Research; 93.397, Cancer Centers Support; 

93.398, Cancer Research Manpower; 93.399, 

Cancer Control, National Institutes of Health, 

HHS) 

Dated: February 21, 2008. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 08–906 Filed 2–29–08: 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Amended 

Notice of Meeting 

Notice is hereby given of a change in 

the meeting of the National Cancer 

Institute Special Emphasis Panel, April 

7, 2008, 8 a.m. to April 7, 5 p.m., 

Gaithersburg Hilton, 620 Perry Parkway, 

Gaithersburg, MD, 20877 which was 

published in the Federal Register on 

February 15, 2008, 73FR8886–8887. 

This notice is amended to change the 

name from ‘‘Biosensors for Early Cancer 

Detection & Risk Assessment/Novel & 

Improved Methods to Measure Cancer 

Epigenetic Biomarkers’’ to ‘‘Biosensors/ 

Cancer Epigenetic Biomarkers’’. The 

meeting is closed to the public. 

Dated: February 25, 2008. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 08–908 Filed 2–29–08; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Eye Institute; Notice of 

Closing Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

mended (5 U.S.C. Appendix 2), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in section 

552b(c)(6), Title 5 U.S.C., as amended. 

The grant applications and the 

discussions could disclose confidential 

trade secrets or commercial property 

such as patentable material, and 

personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Eye Institute 

Special Emphasis Panel, NEI Cooperative 

Agreement Review. 

Date: March 6, 2008. 

Time: 9 a.m. to 11 a.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 5635 

Fishers Lane, Bethesda, MD 20892 

(Telephone Conference Call). 

Contact Person: Houmam H. Araj, PHD, 

Scientific Review Administrator, Division of 

Extramural Research, National Eye Institute, 

NIH, 5635 Fishers Lane, Suite 1300, 

Bethesda, MD 20892–9602, 301–451–2020, 

Haraj@mail.nih.gov. 

This notice is being published less than 15 

days prior to the meetings due to the timing 

limitations impose by the review and funding 

cycle. 

Name of Committee: National Eye Institute 

Special Emphasis Panel, NEI Cooperative 

Agreement Review. 

Date: March 20, 2008. 

Time: 12 p.m. to 1 p.m. 

Agenda: To review and evaluate grant 

applications. 


rmajette on PROD1PC64 with NOTICES
11424 Federal Register / Vol. 73, No. 42 / Monday, March 3, 2008 / Notices 

Place: National Institutes of Health/NEI, 

5635 Fishers Lane, Bethesda, MD 20892 

(Telephone Conference Call). 

Contact Person: Anne E. Schaffner PHD, 

Scientific Review Administrator, Division of 

Extramural Research, National Eye Institute, 

NIH, 5635 Fishers Lane, Suite 1300, MSC 

9300, Bethesda, MD 20892–9300, 301–451–

2020, aes@nei.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.867, Visions Research, 

National Institutes of Health, HHS) 

Dated: February 25, 2008. 

Jennifer Spaeth. 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 08–903 Filed 2–29–08; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute On Deafness and 

Other Communication Disorders; 

Notice of Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of a meeting of the 

Board of Scientific Counselors, NIDCD. 

The meeting will be open to the 

public as indicated below, with 

attendance limited to space available. 

Individuals who plan to attend and 

need special assistance, such as sign 

language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. The meeting 

will be closed to the public as indicated 

below in accordance with the provisions 

set forth in section 552b(c)(6), Title 5 

U.S.C., as amended for the review, 

discussion, and evaluation of individual 

intramural programs and projects 

conducted by the National Institute On 

Deafness and Other Communication 

Disorders, including consideration of 

personnel qualifications and 

performance, and the competence of 

individual investigators, the disclosure 

of which would constitute a clearly 

unwarranted invasion of personal 

privacy. 

Name of Committee: Board of Scientific 

Counselors, NIDCD. 

Date: March 28, 2008. 

Open: 8 a.m. to 8:30 a.m. 

Agenda: Other. 

Place: National Institutes of Health, 5 

Research Court, 2A08, Rockville, MD 20852. 

Closed: 8:30 a.m. to 5 p.m. 

Agenda: To review and evaluate personal 

qualifications and performance, and 

competence of individual investigators. 

Place: National Institutes of Health, 5 

Research Court, 2A08, Rockville, MD 20852. 

Contact Person: Robert J. Wenthold, PhD, 

Director, Division of Intramural Research, 

National Institute On Deafness and Other 

Communication Disorders, 5 Research Court, 

Room 2B28, Rockville, MD 20852, 301–402–

2829. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice. The statement should include the 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

In the interest of security, NIH has 

instituted stringent procedures for entrance 

onto the NIH campus. All visitor vehicles, 

including taxicabs, hotel, and airport shuttles 

will be inspected before being allowed on 

campus. Visitors will be asked to show one 

form of identification (for example, a 

government-issued photo ID, driver’s license, 

or passport) and to state the purpose of their 

visit. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.173, Biological Research 

Related to Deafness and Communicative 

Disorders, National Institutes of Health, HHS) 

Dated: February 25, 2008. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 08–901 Filed 2–29–08: 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Deafness and 

Other Communication Disorders; 

Notice of Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute on 

Deafness and Other Communication 

Disorders Special Emphasis Panel, The 

Research Core Center Review. 

Date: March 25, 2008. 

Time: 1:30 p.m. to 4 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6120 

Executive Blvd., Rockville, MD 20852 

(Telephone Conference Call). 

Contact Person: Christine A. Livingston, 

PhD, Scientific Review Administrator, 

Division of Extramural Activities, National 

Institutes of Health/NIDCD, 6120 Executive 

Blvd.—MSC 7180, Bethesda, MD 20892, 

(301) 496–8683, livingsc@mail.nih.gov. 

Name of Committee: National Institute on 

Deafness and Other Communication 

Disorders Special Emphasis Panel, Loan 

Repayment Program. 

Date: May 1, 2008. 

Time: 1 p.m. to 4 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6120 

Executive Blvd., Rockville, MD 20852 

(Telephone Conference Call). 

Contact Person: Stanley C. Oaks, PhD, 

Scientific Review Administrator, Division of 

Extramural Activities, NIDCD, NIH, 

Executive Plaza South, Room 400C, 6120 

Executive Blvd.—MSC 7180, Bethesda, MD 

20892–7180, (301) 496–8683, so14s@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.173, Biological Research 

Related to Deafness and Communication 

Disorders, National Institutes of Health, HHS) 

Dated: February 25, 2008. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 08–902 Filed 2–29–08; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Arthritis and 

Musculoskeletal and Skin Diseases; 

Notice of Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Arthritis and Musculoskeletal and Skin 

Diseases Special Emphasis Panel, Muscular 

Dystrophy Cooperative Research Centers. 

Date: March 20–21, 2008. 

Time: 7 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Gaithersburg Marriott 

Washingtonian Center, 9751 Washingtonian 

Boulevard, Gaithersburg, MD 20878. 


rmajette on PROD1PC64 with NOTICES